Diabetes :: New drug to treat type 1 and type 2 diabetes
The Food and Drug Administration (FDA) approved Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone.